Risk factors associated with multi-drug-resistant Acinetobacter baumannii nosocomial infections at a tertiary care hospital in Makkah, Saudi Arabia - a matched case–control study
Open Access
- 8 May 2017
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 45 (3) , 1181-1189
Abstract
To determine risk factors for multi-drug-resistant Acinetobacter baumannii (MDR-AB) nosocomial infections in intensive care units in a tertiary care hospital, Makkah, Saudi Arabia. We performed a hospital-based, matched case–control study in patients who were admitted to Al Noor Specialist Hospital between 1 January 2012 and 31 August 2012. The study included cases of A. baumannii nosocomial infection and controls without infection. Controls were matched to cases by age and ward of admission. The most frequent site of infection was the respiratory tract (77.3%). Susceptibility to antimicrobial MDR-AB was 92.0% for ceftazidime and ciprofloxacin, while it was 83.3% for imipenem, 83.0% for trimethoprim, 79.0% for amikacin, and 72.7% for gentamicin. Multiple logistic regression of risk factors showed that immunosuppression (OR = 2.9; 95% CI 1.5–5.6; p = 0.002), clinical outcome (OR = 0.4; 95% CI 0.3–0.9; p = 0.01), invasive procedures (OR = 7.9; 95% CI 1.8–34.2; p = 0.002), a central venous catheter (OR = 2.9; 95% CI 1.5–5.6; p = 0.000), and an endotracheal tube (OR = 3.4; 95% CI 1.6–7.3; p = 0.001) were associated with MDR-AB. Acinetobacter nosocomial infections are associated with admission to the ICU (Intensive care unit) and exposure to invasive procedures.Keywords
This publication has 20 references indexed in Scilit:
- Rapid control of a hospital‐wide outbreak caused by extensively drug‐resistant OXA‐72‐producing Acinetobacter baumanniiThe Kaohsiung Journal of Medical Sciences, 2011
- Nosocomial imipenem-resistant Acinetobacter baumannii infections: Epidemiology and risk factorsScandinavian Journal of Infectious Diseases, 2010
- Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case–control studyJournal of Hospital Infection, 2009
- Current control and treatment of multidrug-resistant Acinetobacter baumannii infectionsThe Lancet Infectious Diseases, 2008
- Acinetobacter baumannii : Emergence of a Successful PathogenClinical Microbiology Reviews, 2008
- High tigecycline resistance in multidrug-resistant Acinetobacter baumanniiJournal of Antimicrobial Chemotherapy, 2007
- Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary reportJournal of Antimicrobial Chemotherapy, 2006
- Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literatureJournal of Hospital Infection, 2006
- The Epidemiology and Control of Acinetobacter baumannii in Health Care FacilitiesClinical Infectious Diseases, 2006
- Multiresistant acinetobacter in the UK: how big a threat?Journal of Hospital Infection, 2004